Skip to content

Savara SVRA Pre-Tax Income

Pre-Tax Income at other companies

Innoviva, Inc. logo
Innoviva, Inc.INVA
$234.56M+708%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$6.47M+54.2%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$40.22M+101%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$1.57M+205%
TRV
Trevi Therapeutics, Inc.TRVI
-$13.21M-27.6%
PVL
Palvella TherapeuticsPVLA
-$15.77M-92.6%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+134%
Enterprise value$1.19B+127%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: Savara’s 10-Q, filed May 13, 2025, on SEC EDGAR. View the filing →

Ask your AI about Savara's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's pre-tax income?
Savara (SVRA) reported pre-tax income of -$26.64M in Q1 2025.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.